Allstate Corp Takes Position in Avantor, Inc. (NYSE:AVTR)

Allstate Corp purchased a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 20,295 shares of the company's stock, valued at approximately $428,000.

Other hedge funds have also recently modified their holdings of the company. Brown Brothers Harriman & Co. raised its position in shares of Avantor by 0.3% in the 4th quarter. Brown Brothers Harriman & Co. now owns 2,921,765 shares of the company's stock worth $61,562,000 after acquiring an additional 7,800 shares in the last quarter. DnB Asset Management AS grew its stake in Avantor by 4.2% in the fourth quarter. DnB Asset Management AS now owns 132,202 shares of the company's stock valued at $2,785,000 after purchasing an additional 5,268 shares during the last quarter. Pictet Asset Management Holding SA raised its holdings in Avantor by 2.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 6,560,792 shares of the company's stock worth $138,236,000 after purchasing an additional 179,894 shares in the last quarter. New Age Alpha Advisors LLC purchased a new stake in shares of Avantor during the fourth quarter valued at about $1,311,000. Finally, Norges Bank bought a new stake in shares of Avantor in the 4th quarter valued at about $142,512,000. Hedge funds and other institutional investors own 95.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on AVTR shares. Citigroup decreased their target price on shares of Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Barclays decreased their price objective on Avantor from $26.00 to $23.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Cowen reaffirmed a "buy" rating on shares of Avantor in a research report on Tuesday, March 18th. UBS Group reissued a "neutral" rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Raymond James restated an "outperform" rating and set a $24.00 price objective (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $25.50.

Remove Ads

Insider Activity

In other Avantor news, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now owns 87,379 shares of the company's stock, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.

Avantor Stock Performance

NYSE AVTR traded up $0.12 on Monday, hitting $15.25. 12,004,237 shares of the company's stock traded hands, compared to its average volume of 6,654,440. The firm's 50-day moving average price is $17.64 and its two-hundred day moving average price is $20.87. The firm has a market capitalization of $10.39 billion, a PE ratio of 14.66, a P/E/G ratio of 1.55 and a beta of 1.23. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 1-year low of $14.67 and a 1-year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the firm earned $0.22 earnings per share. As a group, analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.